WYETH

Wyeth Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Members of the Exchange are hereby informed that the trading symbol of Wyeth Limited be changed from WYETHLEDE to WYETH w.e.f. September 1, 2006.

Wyeth Limited has informed the Exchange that the Company has on July 31,2006, assigned its leasehold interest in the land at Plot No. 81, MIDC Industrial Area, Satpur, Nashik, and vacant buildings and structures standing thereon, to Mahindra & Mahindra Limited, for a consideration of Rs. 2.50 crores. Further, Forhans Toothpaste and Toothpowder were manufactured by the Company at its manufacturing facility at the said premises. The Forhans brand has been assigned, and know-how to manufacture the above, licensed to John Oak Remedies Pvt. Ltd., for a consideration of Rs. 2.25 crores.

Wyeth Limited has informed the Exchange that the Company is launching on June 30, 2006, in Mumbai, "Prevenar". Prevenar is a 7 - valent Pneumococcal Conjugate vaccine indicated for active immunization of children against invasive pneumococcal disease like sepsis, meningitis, bacteraemic, pneumonia and bacteraemia caused by Streptococcus pneumomiae having serotypes - 4, 6B, 9V, 14, 18C, 19F & 23F.

Wyeth Limited has informed the Exchange that the BODs at its meeting held on June 09, 2006, has recommended a dividend of 250% for the year ended March 31, 2006.

Wyeth Limited has informed the Exchange that the Register of Members of the Company will be closed from August 24,2006 to September 05,2006 (both days inclusive) to determine the Members entitled to dividend, if approved, at the AGM to be held on September 05,2006. Dividend, if approved, at the AGM, will be paid on or after September 09,2006.

Wyeth Limited had informed the Exchange that Wyeth USA (Wyeth), having their offices at 5, Giralda Farms, Madison, New Jersey - 07940, have incorporated a wholly owned subsidiary in India. Wyeth has informed Wyeth Limited (WL) that they wish to launch in India, Prevenear, a pneumococcal 7 valent conjugate vaccine and an original researched product of Wyeth, through this wholly owned subsidiary. WL has agreed to relinquish its rights to market Prevenar in consideration of the payment to it of a fair compensation determined on the basis of a valuation of KPMG. Wyeth and WL have mutually agreed u

Wyeth Limited has informed the Exchange that Wyeth USA (Wyeth), having their offices at 5, Giralda Farms, Madison, New Jersey - 07940, have incorporated a wholly owned subsidiary in India. Wyeth has informed Wyeth Limited (WL) that they wish to launch in India, Prevenear, a pneumococcal 7 valent conjugate vaccine and an original researched product of Wyeth, through this wholly owned subsidiary. WL has agreed to relinquish its rights to market Prevenar in consideration of the payment to it of a fair compensation determined on the basis of a valuation of KPMG. Wyeth and WL have mutually agreed u

Wyeth Limited has informed the Exchange that Wyeth Limited (WL) is a subsidiary of Wyeth, USA, (Wyeth) having their Offices at 5, Girlda Farms, Madison, New Jersey - 07940, USA. Wyeth has informed WL that they are in the process of establishing a wholly owned subsidiary in India and as a requirement of Registrar of Companies, Maharashtra (ROC), requested WL to grant a No Obejction letter addressed to the ROC, for the use of the word "Wyeth" as a part of the corporate name of the subsidiary proposed to be incorporated in India. WL has been granted a non-exclusive right to use the trade mark "Wy

Wyeth Limited has informed the Exchange that the auditor's have conducted the limited review of the un-audited financial results for the quarter ended September 30, 2005 and the details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Wyeth Limited has submitted to the Exchange a copy of the Minutes of the AGM of the shareholders of the Company held on September 02, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Wyeth Limited has informed the Exchange that at the meeting of the BODs held on October 26, 2005 the following changes took place in the Directorate of the Company : 1) Mr. Robert Poulton was appointed Director and Chairman of the Company; 2) Mr. A. W. Khandekar was appointed Wholetime Director of the Company.

Wyeth Limited has informed the Exchange that the Ahmedabad Stock Exchange vide its letter dated October 07, 2005 has advised that the Company's equity shares are removed from the list of the said Exchange w.e.f. October 11,2005

Wyeth Limited has informed the Exchange that 1) Dr. A. Bhadra tenderd his resignation as Director of the Company effective September 29, 2005. 2) Mr. B. R. Arora tendered his resignation as Director of the Company effective September 30, 2005. Accordingly, Mr. Arora ceased to be the Chairman of the Board of Directors from that date.

Wyeth Limited has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2005 and the details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Wyeth Limited has informed the Exchange that at the AGM of the Company held on September 02, 2005, all resolutions proposed in the Notice dated June 03, 2005, were passed with requisite majority by the shareholders attending the meeting. A copy of the AGM Notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Wyeth Limited has informed the Exchange that the Board of Directors has approved the sale of forhans brand and grant of knowhow license to manufacture Forhans products for an aggregate consideration of Rs.360 lakhs. In a separate transaction, the Board of Directors, has approved the assignment by the Company of its leasehold interest in the land at Nashik and vacant building and structures thereon to Mahindra & Mahindra Limited for a consideration of Rs.250 lakhs. Negotiations with both parties are in progress.

Wyeth Limited has informed the Exchange that the board of directors in their meeting held on June 03, 2005 has recommended a dividend of 200% (Rs.20/- per equity share of Rs. 10 each) for the year ended March 31, 2005

Wyeth Limited has informed the Exchange that the Register of members of the company will be closed from August 23, 2005 to September 02, 2005 (both days inclusive) to determine the members entitled to dividend, if approved , at the Annual General Meeting to be held on September 02, 2005.

Wyeth Limited has informed the Exchange of the following: 1) All employees at the under mentioned units having availed Voluntary Retirement, the Board of Directors at the Meeting held on May 9, 2005 sanctioned subject to such approvals as may be necessary: a) closure of the Company's manufacturing facility at Atul, Valsad; b) closure of the Company's manufacturing facility at 81, MIDC Area, Satpur, Nashik-422 007; 2) The shareholders had authorized the Board to sell and dispose of the Forhan's brand and business including factory and buildings situate at Nashik as a going concern to John Oak R

Wyeth Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31, 2004 and the details of the same are available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Wyeth Limited has informed the Exchange that the auditors have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2004 and found the same to be in order subject to certain observations. The auditor's observations are: The Govt. of India has demanded amounts aggregating to Rs.1967.92 lakhs from the company under the Drugs (Price Control) Order, 1979. As at September 30, 2004, the company is carrying cumulative provisions of Rs.240.50 lakhs in respect of such demands. Although the company is contesting the demands, it is not possible to predict th